HIGHLIGHTS
- who: Khalid Al Sulaiman from the Box, Riyadh, Saudi Arabia have published the research: Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study, in the Journal: (JOURNAL) of March/01,/2020
- what: This study compared the effectiveness and safety of prophylactic standard-doses of enoxaparin and unfractionated heparin (UFH) in critiu2011 cally ill patients with COVID-19. The study demonstrated no significant difference between enoxaparin and UFH groups in minor or major bleeding occurrence, and the need for blood products transfusion during ICU stay . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.